invIOs Raises €8.2 Million In Series A For Immuno-Oncology
15 Oct 2024 //
GLOBENEWSWIRE
invIOs to attend JP Morgan Week in San Francisco in January
21 Dec 2023 //
GLOBENEWSWIRE
invIOs starts trial of APN401, novel cell therapy against solid cancers
05 Sep 2023 //
GLOBENEWSWIRE
invIOs presents exciting preclinical data showing that immune-activating INV501
19 Jun 2023 //
GLOBENEWSWIRE
invIOs to present at Biotech Showcase
14 Dec 2022 //
GLOBENEWSWIRE
invIOs presents positive patient data from ongoing Phase 1b trial of APN401
10 Nov 2022 //
GLOBENEWSWIRE
invIOs to present data from clinical stage Cbl-b program at SITC 2022
18 Oct 2022 //
GLOBENEWSWIRE
invIOs to present at upcoming industry and investor conferences
11 Oct 2022 //
GLOBENEWSWIRE